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% BF; Percentage Body Fat 
ACSM; American College of Sports Medicine 
AHA; American Heart Association 
BIA; Bioelectrical Impedance Analysis 
BMI; Body Mass Index 
CT; Computerized Tomography 
DXA; Dual-energy X-ray Absorptiometry 
EPIDOS; EPIDemiologie de l’OSteoporose 
EWGSOP; European Working Group on Sarcopenia in Older People 
FM; fat mass;  
GFR; Glomerular Filtration Rate 
HD; Habitual Diet 
HG, Handgrip 
HSC; High Speed Circuit 
IGF-1; Insulin-like Growth Factor 1 
IADL; Instrumental Activities of Daily Living 
LM; Lean Mass 
MRI; Magnetic Resonance Imaging 
MPS; muscle protein synthesis 
mTOR; mechanistic Target of Rapamycin 
PRISMA; Preferred Reporting for Systematic Reviews and Meta-analyses 
PROSPERO; International prospective register of systematic reviews 
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RCH+HD; Ricotta Cheese plus Habitual Diet 
RCTs; Randomized controlled trials 
RPE; Rates of Perceived Exertion  
RM; Repetition Maximum 
SD; Standard Deviation 
SGOT; Serum Glutamic Oxaloacetic Transaminase 
SGPT; Serum Glutamic-Pyruvic Transaminase 
SPPB; Short Physical Performance Battery test 
SMI; Skeletal muscle index; SO, Sarcopenic Obesity 
SH; Strength Hypertrophy 
TASM; Total appendicular skeletal muscle
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Abstract 
Although sarcopenic obesity (SO) poses a major public health concern, a robust approach for 
the optimization of body composition and strength/function in SO has not yet been 
established. The purpose of this systematic review was to assess the effectiveness of 
nutritional (focusing on energy and protein modulation) and exercise interventions, either 
individually or combined, on body composition and strength/function in older adults with SO. 
MEDLINE, the Cochrane Central Register of Controlled Trials, CINAHL and SPORTDiscus 
were searched. Main inclusion criteria comprised sarcopenia as defined by the European 
Working Group on Sarcopenia in Older People (EWGSOP) and obesity defined as % body 
fat ≥ 40 % (women) and ≥ 28 % (men). Randomized controlled trials (RCTs), randomized 
controlled crossover trials and controlled clinical trials with older adults (mean age ≥65 
years) following a nutritional regimen and/or an exercise training program were considered. 
Out of 109 full text articles identified, only two RCTs (61 participants) met the inclusion 
criteria. One study was a nutritional intervention adding 15 g protein·day
-1
 (via cheese 
consumption) to the participants’ habitual diet. The second study was a high-speed circuit 
resistance training intervention. Body composition did not change significantly in either of 
the studies. However, the exercise intervention improved significantly muscle strength and 
physical function. Although this review was limited by the small number of eligible studies, it 
provides evidence for the potential benefits of exercise and highlights the necessity for future 
research to develop effective interventions including dietary and exercise regimens to combat 
sarcopenic obesity.  
 
Keywords: Aged; sarcopenia; obesity; dietary proteins; exercise; systematic review
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1. Introduction  
 
Sarcopenia is defined by the European Working Group on Sarcopenia in Older People 
(EWGSOP) as the age-related decline of muscle mass and strength or function [1]. Low 
strength and muscle mass are associated with poor functional status, physical impairments, 
frailty, increased risk of falls, loss of independence and higher mortality risk [1][2]. It has 
been suggested that in older people, strength is a stronger predictor of functional impairment 
and mortality rates than absolute changes in muscle mass or lean mass alone [3-6]. Secondary 
to functional impairments, muscle atrophy may also contribute to insulin resistance as muscle 
tissue plays the main role in glucose uptake and utilization [7]. According to a recent 
systematic review, the prevalence of sarcopenia may vary from 1 % to 29 % in community-
dwellers and 14-33 % in long-term care populations [8].  
 
Another condition that can promote poor health is obesity, which is defined as ‘abnormal or 
excess body fat accumulation’ [9], and is a growing concern due to its progressively rising 
prevalence rates in older populations [10]. In 2010, 35 % and 28 % of the adults 65 years of 
age and older were reported to be obese in the US and the UK, respectively [11][12]. Similar 
to sarcopenia, obesity can increase the risk of falls and mobility limitations in older age 
[13][14], and when used in conjunction with indices of body composition and fat distribution 
(waist circumference or waist to hip ratio) it may be associated with adverse health effects, 
such as cardiovascular disease, metabolic syndrome, diabetes mellitus and several cancers 
[15]. Furthermore, adipose tissue can infiltrate the muscle tissue [16] and mediate an 
inflammatory response [17], which can result in muscle atrophy, mobility losses and lower 
strength and muscle quality [16][18][19]. 
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The relationship between sarcopenia and obesity is complex, with the development/ 
progression of one condition being closely connected to the other (Figure 1). The condition 
where sarcopenia and obesity occur together has been termed sarcopenic obesity (SO) [20]. It 
has been suggested that SO can predispose older individuals to more physical disabilities, gait 
and balance abnormalities, and an increased risk of falls compared with either of the two 
conditions alone [21]. Individuals with SO are exposed to ~2.5 times higher risk of reporting 
Instrumental Activities of Daily Living (IADL) disabilities compared with adults without 
obesity but with sarcopenia, or adults with obesity but without sarcopenia [22]. This negative 
synergistic effect of sarcopenia and obesity is in accordance with the findings from the 
EPIDOS (EPIDemiologie de l’OSteoporose) study, which reported that among a cohort of 
1,308 women divided in four groups: 1) without sarcopenia or obesity 2) with obesity but not 
sarcopenia 3) with sarcopenia but not obesity and 4) with SO, the latter was the poorest in 
terms of performing physical activities that required strength [23]. According to a meta-
analysis of 12 prospective cohort studies with a total number of 35,287 participants, the 
adults with SO had a 24 % higher risk of all-cause mortality compared with their healthy 
counterparts [24].   
 
 
Although SO has gained significant attention from the scientific community in recent years, 
and a plethora of existing definitions and cut-offs for sarcopenia and obesity exist, there is no 
universally accepted definition for SO [1][25][26].  Depending on the definition criteria and 
cut-offs used the prevalence rates of SO can vary up to 26-fold, which makes detection and 
management of the condition challenging for healthcare practitioners [27]. Moreover, there 
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are operational challenges around the management of SO. While exercise training can be 
beneficial for both obesity and sarcopenia, the dietary management of obesity may require 
energy restriction, whilst management of sarcopenia requires an increased intake of 
macronutrients, especially protein [28].  
 
This has resulted in a growing body of evidence highlighting potentially beneficial nutritional 
and exercise strategies, aiming to reverse or attenuate the negative effects of ageing on body 
composition and physical function [29-31]. Particular focus has been placed on protein 
intake, energy modulation and resistance exercise [32][33]. With regard to protein intake, 
there seems to be a consensus for the benefits of increased protein intake, ranging from 1.0 g· 
kg bw
-1
· day
-1 
to 1.5 g· kg bw
-1
· day
-1
, with the higher values appropriate for those older 
adults with chronic conditions, sarcopenia and malnutrition, or when combined with 
resistance exercise [28][34][35]. 
 
 However, there are relatively few intervention studies utilizing exercise training and/or 
nutritional regimens for older adults with SO [26][36]. It appears that most intervention trials 
have aimed to attenuate muscle loss at an early stage rather than try to ‘reverse’ an 
established condition related to advanced ageing such as sarcopenia or SO, which would be 
far more challenging [37]. Furthermore, to the best of our knowledge, there has been no 
systematic review to date assessing the effectiveness of nutritional and exercise strategies, 
alone or combined, to improve body composition and strength/function indices in older 
individuals with SO. Therefore, the purpose of this systematic review was to assess the 
evidence for the use of diets modulating energy and protein (or amino acids) content, exercise 
training regimens, or diet and exercise training combined, in older adults with SO.   
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The focus of this systematic review was to determine the effectiveness of protein or energy-
modulating regimens, with or without exercise training on body composition and function in 
adults, 65 years of age and older with SO. In particular, our aims were to 1) determine 
changes in absolute muscle mass, total appendicular skeletal muscle (TASM), skeletal muscle 
index (SMI), fat mass, % body fat, body weight and body mass index (BMI), 2) assess 
changes in muscle strength and/or physical function (including muscle strength, power, gait 
speed and balance and 3) evaluate the effect of these interventions on quality of life, 
metabolic profile, activities of daily living, adverse effects of supplementation or food 
choices, compliance rates and changes in habitual dietary intake during or after the 
interventions.   
 
2. Approach 
 
This systematic review was performed according to the Preferred Reporting for Systematic 
Reviews and Meta-analyses (PRISMA) guidelines [38]. The protocol was registered with the 
International prospective register of systematic reviews (PROSPERO registration number: 
CRD42015017311).  
 
2.1. Search Strategy  
 
The Cochrane Central Register of Controlled Trials, MEDLINE (via EBSCOhost Research 
Databases), CINAHL  and SPORTDiscus  were searched up to and including May 2016. The 
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last search was conducted on 22 May 2016. No limits were applied for date of publication. 
Combinations of key terms with Medical Subject Headings (MeSH) and Boolean operators 
were used. The main keywords and terms used were: Age*/ Adult*/ Old*/ Elderly/ Senior, 
Sarcopeni*/ Lean/ Frail/ Atrophy/ Weakness, Obes*/ Overweight/ Body Mass Index, 
Exercise/ Training/ Strength/ Muscle/ Mass/ Hypertrophy/ Size/ Body Composition, Diet/ 
Supplements/ Protein/ Amino Acids/ Energy, Life Quality/ Intervention. The search limiters 
were English language and studies with human participants [the complete search strategy is 
presented in supplemental materials]. 
 
2.2. Inclusion Criteria  
 
We included randomized control trials (RCTs), randomized control crossover trials and 
controlled clinical trials using prospective nutritional and/or exercise interventions to 
attenuate/ reverse the loss of muscle mass, reduce adipose tissue and optimize muscle 
strength or function.  Given that there are no universally adopted definition criteria for SO, 
some authors may have used different terms to define the participants, e.g. ‘weak and 
overweight’ or ‘obese frail’ etc. Such studies were included only if the participants had a 
sarcopenic phenotype based on the definition criteria and cut-off scores recommended by the 
EWGSOP [1]. Therefore, studies were included only if they presented data for a) body 
composition (data on absolute muscle mass, appendicular muscle mass, Total Appendicular 
Skeletal Muscle (TASM) or Skeletal Muscle Index (SMI) assessed by Dual-energy X-ray 
Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Computerised Tomography 
(CT) or Magnetic Resonance Imaging (MRI) and b) muscular strength and/ or physical 
function identified by one of the following tests: handgrip strength, knee flexion/extension, 
peak expiratory flow, gait speed, the Short Physical Performance Battery test (SPPB), the 
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timed up-and-go test or the stair climb power test . The mean age cut-off for inclusion was ≥ 
65 years based on how ‘old age’ is defined in the joint recommendations from the American 
College of Sports Medicine (ACSM) and the American Heart Association (AHA) [39]. The 
inclusion criterion for obesity was defined as mean percentage body fat (% BF) ≥ 28 % in 
men and ≥ 40 % in women [22] or in the absence of % BF data, a BMI ≥ 27 kg·m-2. For any 
given BMI, a person with sarcopenia will have by definition more body fat compared with 
their counterparts without sarcopenia, therefore, adults with sarcopenia can present high-
adiposity at BMIs substantially lower than 30 kg·m
-2
 [40]. Moreover, it is not uncommon for 
studies to recruit participants who would be classified as overweight or obese based on a BMI 
cut-off ranging from 25 to 28 kg·m
-2
 when the focus is on sarcopenic obesity and/or when 
participants come from a non-Caucasian ethnic group [25][26]. Studies that presented neither 
the % BF nor BMI were included only if these indices could be derived from the weight, 
height and body fat mass values, or if the authors of the study when contacted provided the 
essential information. 
 
 Nutritional interventions aiming to promote muscle hypertrophy by macronutrient profile 
modification or weight loss via energy restriction were of primary interest. Studies providing 
extra macronutrients (especially proteins or amino acids and their metabolites) either in the 
form of whole foods or dietary supplements administered through the oral route only were 
considered. Exercise regimens including resistance, balance, aerobic and mixed exercise 
protocols influencing lean mass, fat mass, muscle hypertrophy, strength, power, speed and/ or 
physical functional were also of primary interest.  
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2.3. Exclusion Criteria  
 
Studies were excluded if the protocol involved administration of any kind of prescription 
only/pharmaceutical agents, or any type of supplementation administered via a route other 
than oral. Studies including participants with cachexia or with serious mental and cognitive 
conditions prohibiting adherence to a structured exercise/ nutrition regimen, such as 
Alzheimer’s or dementia, were excluded.  
 
2.4. Study Selection 
 
The titles and abstracts were screened for eligibility (CT), and the full text copies of 
potentially eligible articles were obtained for further inspection. The full-text articles were 
independently assessed for eligibility by two reviewers (CT and JJ). The reference lists of 
eligible articles and review papers as well as journals specializing in older age were hand 
searched for potential articles. Any disagreement between the two reviewers was resolved by 
a third reviewer (CAG).    
 
2.5. Data Extraction 
Data were extracted from each eligible article by two reviewers (CT and CAG). Any 
disagreements between the two reviewers were resolved by discussion until consensus was 
reached. Demographic (age, sex, ethnicity/host country and habitation), methodological 
(study design, sample sizes, duration, nutritional/dietary and/or exercise intervention plan, 
supplement type, dosing/frequency of administration, exercise training 
type/frequency/volume, assessment method, blinding) and outcome data (changes within and 
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between groups, significance, dropout rates, compliance, adverse effects) were compiled in a 
standardized Excel spreadsheet.  
 
2.6. Quality Assessment 
 
The quality of the studies was assessed by two independent reviewers using a modified 
version of the Downs and Black rating scale [41][42]. The Downs and Black scale is one of 
the most credible instruments for the quality assessment of randomized [43] and non-
randomized intervention trials [44]. Modified scoring for Question 27 was performed as 
detailed by Eng et al. [42]: the original scale had a maximum score of 32 but in this review 
Question 27 was modified to score either 0 or 1 point instead of the original 0-5 points. 
Therefore, the maximum total score for the five sections of the scale (reporting, external 
validity, internal validity/bias, internal validity/confounding, power) was 28.  
 
2.7. Principal Summary Measures  
 
The primary outcome measures were 1) differences in mean of skeletal muscle mass (either 
absolute, relative or appendicular) and body fat or BMI, and 2) differences in mean of muscle 
strength and physical function/performance  
 
3. Results  
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3.1. Description of studies 
 
Our search strategy resulted in 1,440 potential articles. After the exclusion of 1,331 articles 
based on titles and abstracts, 109 full-text articles reporting 109 studies were retrieved and 
assessed for eligibility. The detailed flow chart of the selection process is presented in Figure 
2. The authors of two potentially eligible studies [45][46] were contacted for further 
information, but retrieval of all the essential body composition data was not possible for 
reasons unrelated to this review, therefore, the articles were excluded.  A total of n=2 studies 
[47][48] including n= 61 participants met the inclusion criteria and were included in the 
review. Study A[47] was a nutritional intervention and study B[48] an exercise training 
intervention; neither of the studies combined exercise with diet.  
 
 
 
3.2. Quality Assessment  
 
The two studies were randomized control trials of moderate methodological quality based on 
the modified Downs and Black rating scale [41][42]. The total score for each study was 18 
out of 28. The summary key information of the methodological strengths and limitations is 
presented in table 1 (supplemental table S1 presents the complete breakdown of the scoring 
in the different subsections of the scale). Both studies performed power calculations to 
determine the population sample size prior to recruitment, however, study B[48] was 
underpowered; target was n=21 per group, but the final analysis was conducted with n=9 and 
n=8 for the control and intervention group, respectively. In study A[47] only the testers were 
blinded but not the participants. In study B[48] the two groups were exercising at different 
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times, therefore, participants were partially blinded. Study A[47] reported and tested for a 
range of potential confounders, but failed to report essential information regarding the 
participants’ dietary intake at baseline and follow-up. The results in Study A were based on 
an intention-to-treat analysis, whereas in Study B the analysis conducted was per-protocol.  
 
3.3. Participant Characteristics  
 
Participants in study A[47] were physically-independent individuals living in Mexico. Their 
mean± SD age and TASM were 76± 5.4 years and 15.5± 2.9 kg, respectively. The mean % 
BF of men and women was 33.3± 6.2 % and 47.8± 6.6 %, respectively. At baseline two men 
had a % BF < 28 % and three women < 40 %. All participants in study B[48] were 
independent-living community dwellers from South Miami (USA). The mean ± SD age and 
BMI of participants was 71.3 ± 7.8 years and 32.6 ± 4.7 kg · m
-2
, respectively and their mean 
SMI 6.6 ± 1.0 kg · m
-2
.   
 
3.4. Study Design    
 
The aim of study A[47] was to assess whether the addition of a protein rich food to the 
habitual diet could increase TASM and strength in older individuals with sarcopenia. The 
study was a 3-month RCT with a control (habitual diet; HD) and an intervention group 
(habitual diet + 210 g ricotta cheese per day; RCH+HD). The cheese provided 15.7 g extra 
protein (including 8.6 g of essential amino acids), 10.4 g carbohydrate, 18.4 g fat and a total 
of 267 kcal per day.  Cheese was divided into three 70 g portions and participants were 
instructed to consume each portion along with their usual breakfast, lunch and dinner. Dual-
energy x-ray absorptiometry was used to measure TASM and body composition changes.  
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Study B[48] was a 15-week single blind RCT, which aimed to assess the effectiveness of a 
novel exercise regime based on a high speed circuit (HSC) resistance training program 
(intervention) on body composition, muscular performance and IADL compared with a 
conventional strength hypertrophy (SH) regime (control group) in community-dwellers with 
SO. Body composition was assessed by single frequency BIA. Both groups performed 
exercises at 11 pneumatic gym machines twice per week. The SH protocol involved three sets 
of 10-12 repetitions at 70 % of 1RM with a 1-2 min recovery break between sets. Participants 
were instructed to keep a similar speed of contraction  for both the concentric and eccentric 
phase (2 seconds per phase). The HSC group performed 10-12 repetitions at the same 11 
exercises, but in a circuit pattern (i.e. moving from one exercise to the other) with no break in 
between exercises, unless one full circuit was complete. Three full circuits were performed in 
total. The resistance load was selected based on maximum power output for each machine. 
The concentric phase was performed as fast as possible while the eccentric in 2 seconds. No 
dietary or nutritional element was introduced in the study, and neither dietary patterns nor 
intakes were reported.   
 
3.5. Outcomes  
 
3.5.1. Body composition  
 
No significant changes were seen in body composition, in either experimental or control 
groups. In study A[47] the addition of ricotta cheese resulted in no significant changes in lean 
mass, TASM or body fat in the intervention or control group (Table 2). Secondary analysis 
by sex showed that although men (n=8) in the intervention group experienced an increase in 
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TASM by 490 g, this was not significantly different either from baseline or when compared 
against the control group (p=0.42), which gained a non-significant 220 g of TASM.  
Similarly, in study B [42] no statistically significant differences were detected in any of the 
body composition indices, regardless of the exercise regimen (Table 2). Skeletal muscle 
index (SMI) increased non-significantly in both groups (from 6.5 ± 0.66 kg·m
-2
 to 6.6 ± 0.59 
kg·m
-2
 in HSC and from 6.7 ± 0.45 kg·m
-2
 to 6.8 ± 0.42 kg·m
-2
 in SH).  
 
3.5.2 Strength and/ or function 
 
In study A [47], the group receiving the extra protein noted a non-significant trend towards an 
increase in strength (+ 0.9 % relative increase). Although the control group experienced a 
drop in strength (-3.5 %), the difference between the two groups did not achieve statistical 
significance (p=0.06).  
 
Study B [48] reported significant improvements in several aspects of strength and function in 
both exercise groups (Table 2). In particular, the strength-hypertrophy (SH) control group 
experienced significant improvements in leg press 1RM by 22 % (p<0.01), chest press 1RM 
by 16 % (p=0.03), leg press peak power by 19 % (p=0.03) and chest press peak power by 
15% (p<0.01) whereas a non-significant increase of 12% was detected in hand grip strength 
(from 17.3 ± 2.7 kg to 19.4 ± 4.6 kg; p>0.05). The HSC group had a significant improvement 
in chest press 1RM by 21 % (p<0.01), leg press peak power by 41% (p<0.01) chest press 
peak power by 24 % (p<0.01) but hand grip strength did not change significantly (increased 
by 10 %, from 17.7 ± 7.8 kg to 19.4 ± 6.6 kg; p>0.5). Between group differences were 
detected only for leg press peak power, with the HSC group performing better than the 
control by 158 W [95 % CI (2, 315), p=0.005].    
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The Short Physical Performance Battery (SPPB) test improved significantly over time only 
within the HSC group from 8.0 ± 1.5 to 9.6 ±1.2 (p=0.02).  Between group differences 
favored the HSC group [mean difference 1.1 (95 % CI (-0.1, 2.4), p=0.08], although this was 
not statistically significant.  
 
3.5.3 Secondary Outcomes  
 
Consumption of ricotta cheese in study A[47], resulted in significantly lower fasting insulin 
levels in men (p=0.05) but not in women. There were no other significant changes in hepatic 
markers (Serum Glutamic Oxaloacetic Transaminase (SGOT), Serum Glutamic-Pyruvic 
Transaminase (SGPT) and Alkaline Phosphatase), kidney function (blood urea, uric acid, 
creatinine and Glomerular Filtration Rate (GFR)), anabolism (Insulin-like Growth Factor-1 
(IGF-1)) or insulin resistance. No cases of microalbuminuria were present in the RCH+HD 
group after the intervention period. In the intervention group, 25 % of women reported early 
satiety after the consumption of ricotta cheese, however, dietary intakes were not reported. 
Eight participants from the intervention group dropped out; five were due to personal health 
issues, two could not eat the entire portion of ricotta cheese, and one had to relocate. In the 
control group three people dropped out (two for personal reasons and one for modifying the 
habitual diet). However, all participants were measured pre- and post-intervention according 
to an intention-to-treat analysis.      
 
The exercise intervention in study B[48] resulted in acute joint pain only in the SH group. In 
addition, the HSC group reported significantly lower rates of perceived exertion (RPE) with a 
mean difference of -1.5 (95 % CI -2.0,-0.12, p=0.04). Adherence rates were similar in the two 
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groups; 81 % in HSC and 85 % in SH. Regarding the Instrumental Activities of Daily Living 
(IADLs) there were significant improvements within both groups (pre vs post); namely, time 
needed for jacket on and off (from 11.5 ± 3.5 s to 10.2 ± 2.0 s; p=0.04), scarf pick-up (5.2 ± 
1.1 s to 4.7 ± 0.91 s; p<0.01 and pan carry (4.9 ± 0.61 s to 3.9± 0.77 s; p<0.01) improved 
significantly within the control group, while the HSC group experienced significant 
improvements in time for sit-to-stand (from 16.1 ± 5.7 s to 13.4 ± 3.9 s; p=0.02) and pan 
carry (5.4 ± 1.3 s to 4.5 ± 1.2 s; p<0.01). No differences were observed between the two 
groups in the aforementioned IADLs.     
 
In summary, neither of the studies had a significant effect on body composition. The 
introduction of ricotta cheese in the habitual diet of participants in study A[47] aimed to 
increase their protein intake but it was not reported whether or not this was achieved, and if 
so to what extent. In the same study, there was a trend for an increase in strength in the 
intervention group, but this was not significant. The only significant improvement reported 
was the fasting insulin levels, but that was reported only in men in the intervention group. 
Despite the lack of body composition changes, in study B[48], the high speed circuit 
resistance training and strength hypertrophy resistance training protocols significantly 
improved strength, power and function indices. Finally, due to the limited data extracted and 
diversity of methodologies, statistical pooling was not feasible and therefore, a narrative 
analysis was conducted.   
4. Discussion  
 
The aim of this systematic review was to assess the effectiveness of nutritional and/or 
exercise interventions on body composition and strength or function in older adults with 
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obesity and sarcopenia. Although only two studies were identified, the lack of intervention 
trials clearly highlights the need for more research in this area, especially trials combining 
exercise with nutritional approaches targeting this population group. With regard to the main 
outcomes, neither an increase in protein intake by 15g · day
-1
 nor a 15-week resistance 
exercise protocol produced significant improvements in body composition indices. However, 
the exercise intervention (both the control group following a strength-hypertrophy resistance 
exercise protocol and the intervention group utilizing a high-speed power-orientated circuit 
resistance training) reported significant improvements in both strength and function.  
 
4.1 Effects of protein intake on body composition and function in sarcopenic obesity 
 
Study A[47] attempted to utilize the effects of protein on increased skeletal muscle mass 
accretion rates. Although the authors acknowledged that the suggested recommendations for 
protein intake in older individuals with sarcopenia are 1.2- 1.5 g ·kg bw
-1
 ·day
-1
 [47], they did 
not report the participants’ daily protein intake, therefore, it was not corroborated whether 
such intakes were achieved. It has been suggested that maximal muscle protein synthesis 
(MPS) rates in older adults can be achieved using ~35- 40 g protein · meal
-1
 [49-51] or 0.4 g 
protein · kg bw
-1
 · meal
-1
 [51]. A valid question would be whether a daily addition of 210 g 
ricotta cheese (delivering 15.7 g protein [47]) to the habitual diet could practically augment 
muscle mass in older adults with sarcopenia. It is important to note that the cheese servings 
were not consumed in one meal, instead they were spread over the three main meals, that is, 
70 g cheese (~5 g of extra protein per meal) consumed with breakfast, lunch and dinner. 
Protein intakes in Study A[47] were not reported, but if we extrapolate data from studies in 
similar population cohorts [52], it has been suggested that older individuals are not likely to 
consume an adequate amount of protein during all main meals. Tieland et al. [52] reported 
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mean protein intakes of ~8 g, ~18 g and ~29 g for breakfast, lunch and dinner, respectively. 
Therefore, it is uncertain whether the addition of 5 g protein in the main meals in study A[47] 
was enough to significantly augment MPS.  
 
Another confounder may have been the potential impact of the addition of cheese on the 
habitual diet given the fact that 25 % of women in Study A[47] experienced early satiety. It 
could be consequently speculated that women’s habitual diet was modified with the addition 
of ricotta, potentially displacing the intake of other foods. However this cannot be confirmed 
as the habitual diet was not reported.  
 
In study A [47], even though there was a trend towards increased strength, it could be argued 
that higher -and perhaps different distributions of- protein intake [31] were needed to enhance 
muscle strength and accretion of skeletal muscle mass. It should be also noted that the power 
calculation for sample size was based on lean mass as the primary outcome, rather than 
muscle strength. Therefore, it is unknown whether a larger sample size was needed to reveal 
a significant change in handgrip strength. 
 
It has been previously reported that protein supplementation can enhance function in older 
adults. Namely, Tieland et al. [53] provided an oral supplement delivering 15 g of protein 
twice daily (with breakfast and lunch) to older frail adults. This addition resulted in 
significantly enhanced physical performance. The potential for high protein meals to maintain 
or increase muscle mass and strength in older adults has been recently reported by Loenneke 
et al. [54] who showed that one or two meals containing 30-45 g protein · day
-1
 were 
associated with higher lean mass and strength compared with those who did not consume any 
meals over the threshold of 30g protein. 
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4.2 Effects of exercise training on body composition and function in sarcopenic obesity 
 
The mechanisms underpinning the effects of exercise on body composition and function in 
older age are mainly accounted for by regulation of genes, circulating hormone levels (e.g. 
testosterone, IGF-1) and metabolic pathways (especially by activating the mechanistic target 
of rapamycin (mTOR), which is a pathway also activated by leucine-rich protein meals [31]) 
and have been reviewed in detail by Garatachea et al. [55] and McGlory and Phillips [56]. 
However, it is still unclear whether the modulation of these pathways can translate into real-
world benefits for adults with SO.  
 
In study B[48], the aim was to assess the effect of high-speed resistance exercise training on 
indices of SO. In spite of possible methodological limitations, the improvements in strength, 
power and IADL reported in study B[42], provide some evidence that exercise can improve 
several domains of physical performance such as strength and power in  older adults with SO. 
This is in agreement with previous reports supporting the benefits of resistance exercise 
training on clinically important outcomes, even in the absence of increased muscle mass 
[8][31][57]. This may be partly accounted for by the adaptive plasticity in the neuromuscular 
system and skeletal muscle tissue in response to resistance exercise even in advanced older 
age [58]. A significant improvement particularly in power can be very important for 
individuals with SO since muscle power can be a predictor of mobility skills and a more 
influential indicator of physical capacity compared with absolute changes in strength [59]. 
Another interesting finding from study B[48] was the large effect size observed in peak leg 
power achieved by exercising at 50 % 1RM. To a certain extent, this finding may be 
explained by the novel aspect of the study design, that is, the resistance exercise progression 
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protocol. Resistance load would increase only when a power plateau was reached [48]. 
Therefore, the protocol was designed in such a way as to favor maximum power output. 
 
The lack of significant changes in lean mass or muscle mass after exercise training in adults 
with sarcopenia, (which has also been reported elsewhere [8]), may be accounted for by 
protocol-specific differences such as: duration, type, intensity, volume and frequency of 
exercise, as well as the availability of adequate nutrients (protein/amino acids), which are 
needed to elicit an anabolic response and consequently muscle hypertrophy [31]. One 
limitation of study B[48] was the lack of control for dietary intake, which could have partly 
explained the lack of effect on body composition. It has been shown that a bout of resistance 
exercise can stimulate muscle protein synthesis (MPS) to a higher degree than protein 
breakdown, however, in the absence of post-workout provision of nutrients (especially 
protein) it can result in negative net muscle protein balance [60][61], and is a limitation of 
study designs to date.  
 
These data support the potential benefit of a resistance exercise program within lifestyle 
intervention protocols due to its positive effect on muscle strength, power and function in 
older adults with SO. Although no statistically significant body-composition changes were 
reported in the included studies, the significant improvements in strength, power and function 
may be more important for the quality of life of adults with SO than absolute changes in body 
fat or lean mass per se.  
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4.3 Recommendations for future research  
 
More intervention trials should be undertaken to identify effective lifestyle strategies in adults 
with SO, that will inform more robust approaches to combat this condition. Future research 
should also bridge the gap in knowledge with respect to multimodal approaches combining 
resistance exercise training with dietary strategies modulating protein intakes, in order to 
augment muscle mass and strength [32] or fat free mass [62], and potentially alongside an 
energy-deficit diet to promote fat loss [33].  
 
It is important to note that although the need to augment muscle mass is paramount, a 
reduction in fat mass and especially fat infiltrating the muscle tissue is equally important, 
since intermuscular fat can result in mobility limitations [16]. Exercise training can 
preferentially reduce intermuscular adipose tissue more effectively than caloric-restriction 
alone [63]. However, a combination of exercise with caloric-restriction can lead to greater 
losses of total fat mass, which in turn may result in greater improvements in physical 
function, sometimes even at the expense of lean tissue [64][65]. Nevertheless, it is currently 
unknown whether this loss of lean mass may be detrimental in the long term for the life 
quality of an older individual with sarcopenia who has already experienced a large decline in 
muscle mass and strength. 
 
To our knowledge only three studies to date, have reported significantly increased muscle or 
lean mass while concomitantly reducing fat mass [66-68]. The pilot study conducted by 
Maltais et al. [68] was the only one that recruited older overweight adults with a low 
appendicular lean mass index. The authors concluded that 16-weeks of a whole body 
resistance exercise regimen (at 80% 1RM) followed by the consumption of ~13 g dairy 
supplement (chocolate milk with added milk powder) increased lean mass and reduced fat 
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mass even at the absence of caloric restriction (n=8). In the same study, the group  that 
received a soy-based beverage (matched for energy, protein, essential amino acids, 
carbohydrate and calcium content) (n=8), reported significant increases only in lean mass but 
no changes in fat mass. Similar results, but in pre-menopausal women, have been reported by 
Josse et al. [66]. After 16 weeks of mixed exercise training (aerobic and resistance) combined 
with a caloric restriction (500 kcal daily deficit), only the high protein group (30% of total 
energy intake came from protein, half of which was derived from dairy products) experienced 
lean gains concomitant with fat losses. Albeit in younger adults, a recent four-week 
intervention combining 2.4 g protein · kg bw
-1
 · day
-1  
(achieved by consuming 3-4 whey-
based protein beverages daily) with a mixed resistance, plyometric and high-intensity interval 
training alongside an energy deficit regimen resulted in significantly higher lean mass and 
lower body fat [67]. The control group which differed only in protein intake (1.2 g protein · 
kg bw
-1
 · day
-1
) did not experience a significant change in lean mass [67].  
 
Although the effectiveness of the aforementioned paradigms needs to be evaluated in older 
adults with SO, they provide the framework for an initial approach to combat this condition. 
What is primarily lacking from the literature is trials recruiting older adults with SO. 
Additionally, protocols combining a high protein diet (potentially using whey or dairy 
proteins) with a modest caloric deficit along with a well structured exercise training regimen 
could be adopted. Moreover, long-term and follow-up studies with adults with SO who have 
intentionally lost weight should be undertaken, in order to assess the impact of weight loss 
(especially if it comes from lean tissue) on life quality and other comorbidities.    
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4.4 Limitations  
 
The main limitation of this review is the scarcity of data and studies undertaken in older 
groups with SO. We reviewed only studies with participants presenting the sarcopenic 
phenotype, as defined by the EWGSOP [1], using an appropriate methodology to assess body 
composition. Although the EWGSOP reached a consensus in 2010 on the definition and 
assessment of sarcopenia, adopting criteria for low muscle and low strength or function, there 
are recent studies [68][69] that use solely the criterion of low muscle mass to define 
sarcopenia as it was initially proposed [70], without taking into consideration low strength or 
function. In addition, one study conducted before 2010 was excluded because muscle mass 
was assessed using urinary creatinine [71], a method not included in the EWGSOP definition. 
Regarding the two studies included in this review, study B[48] aimed to recruit specifically 
participants with sarcopenic obesity. Study A[47] used sarcopenia as an inclusion criterion, 
and although the mean % BF values met our cut-off criteria for obesity, after personal 
communication with the authors it was reported that although the majority of participants had 
the sarcopenic obesity phenotype, a small proportion (5 out of 40) had a % BF below our cut-
off.  
Although of vital importance, there is an apparent lack of interventions with older adults with 
SO. This is in accordance with Finger et al. [62] who commented that interventions may refer 
to or discuss sarcopenia, however, the number of studies recruiting adults specifically with 
sarcopenia is very limited. This is even more complex with respect to studies on sarcopenic 
obesity, with a number of reviews [26][36][33][72] presenting interventions with participants 
who either had none or only one of the conditions (sarcopenia or overweight/obesity but not 
both) and extrapolate these results to propose ways to improve the sarcopenic obesity 
phenotype.  An example of an intervention study is that by Gadelha et al. [73] investigating 
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the effect of exercise training on changes in the sarcopenic obesity index (assessed by the 
residuals method initially presented by Newman et al. [40] and adopted by the EWGSOP) of 
older Brazilian women. However, older age was the main inclusion criterion and no criteria 
specific for sarcopenia or obesity were adopted.  
 
4.5 Conclusion  
 
This review assessed studies investigating the effectiveness of exercise or nutritional 
interventions to improve the body composition and strength/function of older adults with 
sarcopenia and obesity. None of the included studies significantly reduced body fat or 
increased either skeletal muscle mass or lean mass. Although the number of included studies 
was low, it is evident that exercise training can elicit significant improvements in aspects of 
physical fitness such as muscle strength and power, and consequently improve performance 
in activities of daily living in adults with SO. The addition of 15 g protein·day
-1
 to the 
habitual diet via cheese consumption revealed a non-statistically significant trend towards 
increased handgrip strength, and a significantly better insulin response in men, but not in 
women. The lack of published data highlights the necessity for new research adopting 
universally accepted cut-offs for sarcopenic obesity, with the inclusion of appropriately 
designed exercise programs and dietary regimens, and with detailed assessments of dietary 
patterns and protein intakes for the targeted population group. 
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Figure 1. Relationship between sarcopenia and obesity and associated risks as well as 
management strategies. Notes: Solid arrow: direct and positive association; Dashed line 
management strategy attenuating/reversing the condition:     
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
36 
 
 
Figure 2. Information flow through the phases of the systematic review according to 
PRISMA guidelines.
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Table 1. Summary key points of the included study designs. 
Study  Summary Strengths Limitations 
Study A  
Aleman-
Mateo et al. 
[47]  
 
o Nutritional 
Intervention 
o 40 participants  
o 3 months 
o Habitual diet plus 
210g Ricotta cheese 
·day
-1
 
(intervention) vs 
habitual diet 
(control)  
 
o Intention to treat 
analysis 
o Body composition 
by dual-energy xray 
absorptiometry 
o Physically-
independent 
participants.  
o Baseline and follow 
up clinical tests for 
kidney and liver 
function 
o Blinded personnel 
delivering the 
assessment tests.  
o Lack of baseline 
and follow up 
dietary intake and 
physical activity 
data  
 
 
Study B  
Balachandran 
et al. [48] 
 
o Exercise 
Intervention  
o 21 participants  
o 15 weeks 
o High speed circuit 
resistance (HSC)  
training 
(intervention) vs 
strength hypertrophy 
(SH) resistance 
training (control)   
o Independent living 
community-
dwellers.  
o Participants were 
partially blinded to 
the intervention. 
o Testing personnel 
blinded 
o All sessions 
supervised by 2 
physiology majors 
o No allocation 
concealment 
o Per-protocol 
analysis  
o Underpowered 
o Characteristics of 
participants lost to 
follow-up not 
described 
o No description of 
the exercise setting 
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Table 2. Summary of the included studies 
Study Setting/ 
Study Design/ 
Duration 
Group Participants Mean 
Age  (SD)/ 
characteristics 
Exercise 
Training  
Nutritional 
Intervention 
Sample 
Size (n) 
Assessment of  
a)body 
composition b) 
strength or 
function 
Outcome 
Measure  
Drop-out 
(DO n) 
Female (F 
n) 
Adherence 
(%) 
Study A 
(Aleman-
Mateo et al. 
[47])   
Mexico/ RCT: 
two arms, one 
control, one 
intervention / 
3 months 
Control  76.7 (5.8) / 
physically-
independent, 
sarcopenic based on 
low TASM and 
strength, obese 
based on %BF 
No Habitual diet 
(HD) 
Baseline 
n=20, Final 
n= 12 
a) DXA 
 
TASM→, 
FM→, LM→, 
HG→  
DO n= 3 
F n=12 b) HG strength 
N/A 
  Intervention 75.4 (5.0)/ 
independent living 
sarcopenic based on 
low TASM and 
strength, obese 
based on %BF 
No HD plus 210 g 
of ricotta 
cheese/day, 
(providing 15.7 
gr extra 
protein/day) 
Baseline 
n=20, Final 
n=17 
 TASM→, 
FM→ , LM→, 
HG→ 
DO n=8 
F n=11 
N/A 
Study B 
(Balachandran 
et al. [48]) 
USA/ RCT: 
Two arms, one 
control, one 
intervention/ 
15 weeks 
Control 71 (8.2)/ 
independent living 
community dwellers 
from South Miami, 
sarcopenic based on 
SMI and strength, 
obese based on 
%BF and BMI 
Strength-
hypertrophy 
(SH) training, 11 
exercises, 3 sets 
of 10-12 reps per 
set at 70% 1RM  
No Baseline 
n=10, 
Final n=9 
a) BIA 
 
SMI→, 
%BF→, 
SPPB→, Leg 
1RM↑**, Leg 
Power↑*, 
Chest 1RM↑*, 
Chest 
Power↑**, 
HG→ 
 
DO n= 1 
F n=8 b) HG  strength, 
SPPB, Leg 
press 1RM, 
Chest press 
1RM, Leg press 
power, Chest 
press power, 
85% 
  Intervention 71.6 (7.8)/ 
independent living 
community dwellers 
from South Miami 
High speed 
circuit (HSC) 
training, 11 
exercises:  3 
No Baseline 
n=11, 
Final n= 8 
 SMI→, 
%BF→, 
SPPB↓*, Leg 
1RM→, Leg DO n= 3 
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circuits of 10-12 
reps per exercise 
at loads that 
maximised peak 
power output 
F n =8 Power↑**ǂ, 
Chest 
1RM↑**, 
Chest 
power↑**, 
HG→ 
81% 
Notes: → no significant change, ↑significant increase, ↓significant decrease, *<0.05, **<0.01, ǂ significantly better than the control group;  
%BF, percent body fat; BMI, body mass index; DXA, dual-energy xray absorptiometry; FM, fat mass; HG, handgrip; LM, lean mass; RCT, 
randomised control Trial; RM, repetition maximum; SPPB, short physical performance battery test; TASM, total appendicular skeletal muscle.  
 
 
